Literature DB >> 16314424

Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal.

Jillian Taylor1, Sara K Grote, Jianrun Xia, Mark Vandelft, Joanna Graczyk, Lisa M Ellerby, Albert R La Spada, Ray Truant.   

Abstract

Spinocerebellar ataxia type 7 is a progressive neurodegenerative disorder caused by a CAG DNA triplet repeat expansion leading to an expanded polyglutamine tract in the ataxin-7 protein. Ataxin-7 appears to be a transcription factor and a component of the STAGA transcription coactivator complex. Here, using live cell imaging and inverted fluorescence recovery after photobleaching, we demonstrate that ataxin-7 has the ability to export from the nucleus via the CRM-1/exportin pathway and that ataxin-7 contains a classic leucine-type nuclear export signal (NES). We have precisely defined the location of this NES in ataxin-7 and found it to be fully conserved in all vertebrate species. Polyglutamine expansion was seen to reduce the nuclear export rate of mutant ataxin-7 relative to wild-type ataxin-7. Subtle point mutation of the NES in polyglutamine expanded ataxin-7 increased toxicity in primary cerebellar neurons in a polyglutamine length-dependent manner in the context of full-length ataxin-7. Our results add ataxin-7 to a growing list of polyglutamine disease proteins that are capable of nuclear shuttling, and we define an activity of ataxin-7 in the STAGA complex of trafficking between the nucleus and cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314424     DOI: 10.1074/jbc.M506751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.

Authors:  Natalia B Nedelsky; Maria Pennuto; Rebecca B Smith; Isabella Palazzolo; Jennifer Moore; Zhiping Nie; Geoffrey Neale; J Paul Taylor
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

2.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 3.  Insights into SAGA function during gene expression.

Authors:  Susana Rodríguez-Navarro
Journal:  EMBO Rep       Date:  2009-07-17       Impact factor: 8.807

Review 4.  Nuclear transport, oxidative stress, and neurodegeneration.

Authors:  Vivek P Patel; Charleen T Chu
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

5.  Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunction.

Authors:  Stephan J Guyenet; Shona S Mookerjee; Amy Lin; Sara K Custer; Sylvia F Chen; Bryce L Sopher; Albert R La Spada; Lisa M Ellerby
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

Review 6.  New developments in RAN translation: insights from multiple diseases.

Authors:  John Douglas Cleary; Laura Pw Ranum
Journal:  Curr Opin Genet Dev       Date:  2017-03-30       Impact factor: 5.578

7.  Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network.

Authors:  Yoko Nakamura; Kazuhiko Tagawa; Tsutomu Oka; Toshikazu Sasabe; Hikaru Ito; Hiroki Shiwaku; Albert R La Spada; Hitoshi Okazawa
Journal:  Hum Mol Genet       Date:  2011-11-18       Impact factor: 6.150

8.  Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.

Authors:  Jason P Chua; Satya L Reddy; Zhigang Yu; Elisa Giorgetti; Heather L Montie; Sarmistha Mukherjee; Jake Higgins; Richard C McEachin; Diane M Robins; Diane E Merry; Jorge A Iñiguez-Lluhí; Andrew P Lieberman
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

Review 9.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Nucleocytoplasmic shuttling activity of ataxin-3.

Authors:  Sandra Macedo-Ribeiro; Luísa Cortes; Patrícia Maciel; Ana Luísa Carvalho
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.